BSE Live
Jan 01, 16:01Prev. Close
73.25
Open Price
72.11
Bid Price (Qty.)
72.30 (1)
Offer Price (Qty.)
76.49 (50)
NSE Live
Jan 01, 15:41Prev. Close
73.32
Open Price
71.50
Bid Price (Qty.)
73.02 (10)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Bal Pharma (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 186.00 | 176.55 | 146.64 | 139.05 | 114.63 | |
| Less: Excise/Sevice Tax/Other Levies | 3.54 | 3.14 | 2.33 | 2.56 | 2.21 | |
| Revenue From Operations [Net] | 182.46 | 173.41 | 144.30 | 136.49 | 112.42 | |
| Total Operating Revenues | 187.13 | 178.87 | 147.91 | 139.69 | 114.44 | |
| Other Income | 1.19 | 0.65 | 0.66 | 1.08 | 0.54 | |
| Total Revenue | 188.32 | 179.52 | 148.57 | 140.76 | 114.98 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 96.12 | 89.12 | 72.10 | 71.85 | 60.44 | |
| Purchase Of Stock-In Trade | 6.23 | 5.15 | 4.40 | 3.75 | 3.16 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -3.15 | 0.96 | 2.45 | 1.20 | -2.07 | |
| Employee Benefit Expenses | 31.96 | 28.12 | 23.57 | 21.15 | 18.14 | |
| Finance Costs | 6.52 | 7.16 | 7.98 | 7.30 | 6.79 | |
| Depreciation And Amortisation Expenses | 7.00 | 4.74 | 4.81 | 4.13 | 3.42 | |
| Other Expenses | 38.44 | 37.64 | 28.18 | 26.92 | 23.99 | |
| Total Expenses | 183.12 | 172.89 | 143.48 | 136.31 | 113.88 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 5.20 | 6.63 | 5.09 | 4.46 | 1.10 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 5.20 | 6.63 | 5.09 | 4.46 | 1.10 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 1.05 | 1.34 | 1.03 | 0.98 | 0.24 | |
| Less: MAT Credit Entitlement | -0.77 | -0.18 | 1.03 | 0.89 | 0.20 | |
| Deferred Tax | -0.61 | 0.00 | 0.82 | 0.61 | 0.59 | |
| Tax For Earlier Years | -0.02 | 0.03 | -0.01 | 0.00 | 0.00 | |
| Total Tax Expenses | 1.18 | 1.55 | 0.81 | 0.70 | 0.63 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 4.02 | 5.07 | 4.28 | 3.76 | 0.47 | |
| Profit/Loss From Continuing Operations | 4.02 | 5.07 | 4.28 | 3.76 | 0.47 | |
| Profit/Loss For The Period | 4.02 | 5.07 | 4.28 | 3.76 | 0.47 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 3.14 | 4.77 | 4.05 | 3.57 | 0.45 | |
| Diluted EPS (Rs.) | 3.11 | 4.60 | 4.05 | 3.57 | 0.45 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 42.38 | 36.46 | 27.87 | 27.22 | 23.53 | |
| Indigenous Raw Materials | 41.81 | 41.00 | 34.69 | 34.88 | 29.91 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 1.21 | 1.34 | 1.21 | 1.12 | 1.23 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 1.29 | 1.11 | 0.79 | 0.00 | 0.00 | |
| Tax On Dividend | 0.26 | 0.19 | 0.13 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 10.00 | 10.00 | 8.00 | 0.00 | 0.00 |
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y